GMRS · GMR Solutions Inc.
$9.98
+0.09 (+0.91%)
At close · Oct 5
Return incl. dividend (before tax)
Market Cap
$597.48M
Shares
54.02M
Volume · Oct 5
435.97K
Avg daily vol (3M)
812.06K
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$9.89
Open$9.47
Day$9.42–9.91
Available close range$9.42–15.74
Avg vol 30d1.0M
Short int2.5M · 4.7% float · 3.7d
Short vol62%
Last earningsAug 13, 2026
DataMay 2026–Oct 2026
Filing10-Q · Aug 12
The closing range uses available history since May 13, 2026; less than a full year is stored.
Up next
filed Aug 12, 2026
call held Aug 13, 2026
Metrics snapshot
Useful current figures from the complete screener profile.
Revenue (TTM)
—
Trailing 12 months
Net income (TTM)
—
Trailing 12 months
Revenue growth YoY
+3.3%
Year over year
Operating margin
—
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
−$3.93B
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
-57.7%
Year over year · fewer shares
Price change (1Y)
—
Trailing year
Short interest
4.7%
Latest settlement · 3.7 days to cover
AI Brief
Q2 FY26 earnings call · Aug 13, 2026
Q2 FY26
TL;DR. GMR Solutions reported Q2 2026 revenue up 3.3% to $1.49B with adjusted EBITDA down 11.8% to $284.5M (largely due to a $74M prior-year NSA estimate comp and ~$16M ACA exchange payer-mix headwind), a swing to a $28.3M net loss driven by $142.3M of IPO-related expenses, and reaffirmed full-year guidance while flagging continued Iran-conflict fuel/cost pressure.
Bullish
- + Q2 revenue grew 3.3% YoY to $1,490.3M with continued momentum in emergent services
- + Liquidity strengthened with $420M cash and ~$696M undrawn ABL capacity following IPO capital actions and credit rating upgrade
- + Net leverage already at 3.5x (down from 4.3x) with line of sight to below 3.3x by year-end and 3.0x by end of 2027
- + 911 Nurse Navigation scaled to 29 communities / 19.7M covered lives with calls up 50% YoY and four more implementations planned
Bearish
- − Adjusted EBITDA fell 11.8% YoY to $284.5M as margin pressure from ACA exchange subsidy expiration and higher costs weighed on results
- − Net loss of $28.3M in Q2 vs. $80.8M net income prior year, driven by $142.3M of IPO-related stock comp and professional fees
- − Total operating expense rose 19.4% YoY to $1.43B, with employee wages up 24.5% and fuel/maintenance up 21.1% on Iran-conflict and aircraft maintenance timing
- − CapEx and aircraft financing stepped up to 6.3% of revenue vs. 4.5% prior year due to pull-forward of purchases
- − Year-over-year No Surprises Act/IDR revenue estimate tailwind was $74M lower, creating a meaningful comparability drag
From the call
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Equibles Rating
blended score · not investment adviceOverall
Sell
SellHoldBuy
Technical
Sell
Momentum
Limited
Sentiment
Neutral
Fundamentals
Limited
Quant / Vol
Very High
Market backdrop
VIX 15.3 · calm
Equity put/call 0.58
Technical
price trend
50 / 200-day cross
No cross
Price vs 50-day avg
−21%
below
RSI (14)
33
neutral
MACD trend
Negative
52-week position
7%
near low
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
Not enough data for a confident read.
Sentiment
smart money
Trend (MA cross)
No cross
50/200-day averages unavailable
Institutional flow
Accumulating
+62 funds added
Insider flow
Distributing
Net -$28.7M over 90 days · 100% sells
Short interest
Falling
4.68% of float · ▼ -21.9% MoM · 3.7 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
62 holders — 13F breadth
Squeeze score
46
elevated · 0–100
Fundamentals
Not enough data for a confident read.
Quant / Vol
risk profile
Volatility
67%
annualized · 1-yr
Max drawdown
−40%
past year
ATR
7.4%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Latest guidance
· from the Earnings Call filed Aug 13, 2026
Revenue
· full year
$5.89B – $6.18B
Adjusted EBITDA
· full year
Non-GAAP
$1.14B – $1.2B
Total cash used for CapEx and aircraft financing
· full year
5.1% – 5.3%
Total cash used for CapEx and aircraft financing as a percent of
· full year
5.1% – 5.3%
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders Sell
50 / 200-day cross
No cross
Neutral
Price vs 50-day avg
−21%
Bearish
RSI (14)
33
Neutral
MACD trend
Negative
Bearish
52-week position
7%
Bearish
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross)
No cross
50/200-day averages unavailable
Institutional flow
Accumulating
+62 funds added
Insider flow
Distributing
Net -$28.7M over 90 days · 100% sells
Short interest
Falling
4.68% of float · ▼ -21.9% MoM · 3.7 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
62 holders — 13F breadth
Price context
position in its available closing range
Range low $9
Now $10 · 7%
Range high $16
vs 50-day avg -21%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Adjusted EBITDA non-GAAP | 589.59M | Six Months Ended June 30, 2026 | — |
| Air base count | 385 | Six Months Ended June 30, 2026 | — |
| Cash used in aircraft financing arrangements | 52.48M | Six Months Ended June 30, 2026 | — |
| EBITDA non-GAAP | $134.51M | Three Months Ended June 30, 2026 filing | — |
| Emergent air transport requests | 155,790 | Six Months Ended June 30, 2026 | — |
| Emergent transports | 1,683,248 | Six Months Ended June 30, 2026 | — |
| Flights | 70,494 | Six Months Ended June 30, 2026 | — |
| Ground transports | 2,019,992 | Six Months Ended June 30, 2026 | — |
| Lender Defined Adjusted EBITDA non-GAAP | $288.07M | Three Months Ended June 30, 2026 filing | — |
| Net cash capital expenditures | 120.41M | Six Months Ended June 30, 2026 | — |
| Net transport revenue per ambulance transport | $1,365 | Six Months Ended June 30, 2026 | — |
| Non emergent transports | 407,238 | Six Months Ended June 30, 2026 | — |
| Non-transport | 552,400 | Six Months Ended June 30, 2026 | — |
| Nurse Navigation encounters | 57,031 | Six Months Ended June 30, 2026 | — |
| Same market revenue growth | 5.7% | Six Months Ended June 30, 2026 | — |
| Total ambulance transports | 2,090,486 | Six Months Ended June 30, 2026 | — |
| Total patient encounters | 2,714,600 | Six Months Ended June 30, 2026 | — |
| Weather cancellation rate for emergent air transports | 16.3% | Six Months Ended June 30, 2026 | — |
| Wheelchair transports | 14,683 | Six Months Ended June 30, 2026 | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
Medical Care Facilities — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
GMRS
this stock
GMR Solutions Inc.
|
$597.48M | — | — | — | 4.7% |
|
HCA
HCA Healthcare, Inc.
|
$96.64B | -8.6% | +7.1% | 15.0 | 2.9% |
|
FSNUY
Fresenius SE & Co. KGaA
|
$29.92B | -13.3% | — | — | 0.0% |
|
THC
Tenet Healthcare Corp
|
$20.91B | +30.1% | +0.9% | 10.0 | 2.5% |
|
FMS
Fresenius Medical Care AG
|
$12.08B | -6.6% | +5.9% | — | 0.5% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Smart Money
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| GMRS | -10.6% | -26.3% | — | +2.7% | — |
| SPY | -0.2% | -0.5% | +12.2% | +0.9% | +12.9% |
| vs SPY | -10.4% | -25.8% | — | +1.8% | — |